Lab test

Trans-hormone Wellness Panel

This panel supports health monitoring for individuals transitioning from male to female or female to male.

Typical price

From $149

Results

1-3 business days

Preparation

See preparation notes below

Sample

Blood draw or sample collection at a local center

This panel supports health monitoring for individuals transitioning from male to female or female to male. Hormone therapy can affect many body systems, so regular blood work is used to follow hormone levels together with markers of metabolic, blood, and organ health. The panel typically combines sex hormones with binding proteins, pituitary signals, a complete blood count, a metabolic panel, and a lipid panel. The goal is to give a healthcare provider a broad view of how therapy is progressing and whether anything needs attention. Results are interpreted with treatment goals, medication timing, and clinical findings.

• Estradiol The most potent estrogen, relevant during feminizing hormone therapy.
• Total Testosterone A combined measure of bound and unbound testosterone.
• Free Testosterone The unbound, biologically active portion of testosterone.
• FSH Follicle-stimulating hormone, which may change with therapy.
• LH Luteinizing hormone, which may change with therapy.
• Prolactin A pituitary hormone that can be affected by some hormone regimens.
• SHBG Sex hormone binding globulin, which binds sex hormones.
• Complete Blood Count (CBC) Includes red blood cell measures that hormone therapy can influence.
• Comprehensive Metabolic Panel (CMP) Assesses kidney and liver function, electrolytes, and blood glucose.
• Lipid Panel Cholesterol and triglyceride measurements for cardiovascular risk.

• Individuals receiving feminizing hormone therapy
• Individuals receiving masculinizing hormone therapy
• Those starting or adjusting a hormone regimen
• People whose provider wants to monitor metabolic and hormone markers together

• Collection timing may be coordinated with your hormone schedule; follow your provider's instructions
• Fasting is often recommended for the lipid and metabolic components
• Report all hormone medications and supplements to the laboratory

Hormone values are compared against ranges relevant to the person's treatment goals, while metabolic, blood, and lipid measures are compared against standard ranges. The panel helps show whether hormone levels are in the target range and whether any related markers need attention. Because results depend on the specific regimen and timing, they are interpreted by the prescribing healthcare provider. This testing does not itself determine treatment or dosage.

• Alabama
• Alaska
• Arizona
• Arkansas
• California
• Colorado
• Connecticut
• Delaware
• Florida
• Georgia